| 產(chǎn)品名稱 | Aprepitant |
| 產(chǎn)品貨號(hào) | Axon 1486 CAS [170729-80-3] MF C23H21F7N4O3MW 534.43 Purity: 99% Optical purity: Optically pure Soluble in DMSO Description Substance P antagonist (SPA), having effect by blocking the neurokinin 1 (NK1) receptor References Certificates Categories Extra info K Ranga and R Krishnan. Clinical experience with substance P receptor (NK1) antagonists in depression. J. Clin. Psychiatry 2002, 63 Suppl 11, 25-9. ? AK Majumdar et al. Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe. Clin. Pharmacol. Ther. 2003, 74, 150–156.? Certificate of Analysis Material Safety Data Sheet CNS Pain & Inflammation A9 Tachykinin (NK) Substance P antagonist (SPA); NK1 inhibitor Chemical name 5-[(2R,3S)-2-[(R)-1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy]-3-(4-fluoro-phenyl)-morpholin-4-ylmethyl]-2,4-dihydro-[1,2,4]triazol-3-one Parent CAS No. [170729-80-3] Order Size Unit Price Stock 5 mg €95.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
AprepitantAxon 1486 CAS [170729-80-3] MF C23H21F7N4O3
Description
Substance P antagonist (SPA), having effect by blocking the neurokinin 1 (NK1) receptor
Substance P antagonist (SPA); NK1 inhibitor
Chemical name5-[(2R,3S)-2-[(R)-1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy]-3-(4-fluoro-phenyl)-morpholin-4-ylmethyl]-2,4-dihydro-[1,2,4]triazol-3-one Parent CAS No.[170729-80-3] |
| 產(chǎn)品資料 |
